Division of Nephrology, Department of Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan.
Center for Innovative Research for Communities and Clinical Excellence, Fukushima Medical University, Fukushima, Japan.
BMJ Open. 2019 Jul 11;9(7):e028856. doi: 10.1136/bmjopen-2018-028856.
OBJECTIVES: We aimed to examine the validity of the quick Sequential Organ Failure Assessment (qSOFA) score for mortality and bacteraemia risk assessment in Japanese haemodialysis patients. DESIGN: This is a retrospective multicentre cohort study. SETTING: The six participating hospitals are tertiary-care institutions that receive patients on an emergency basis and provide primary, secondary and tertiary care. The other participating hospital is a secondary-care institution that receives patients on an emergency basis and provides both primary and secondary care. PARTICIPANTS: This study included haemodialysis outpatients admitted for bacteraemia suspicion, who had blood drawn for cultures within 48 hours of their initial admission. PRIMARY AND SECONDARY OUTCOME MEASURES: The primary outcome measure was overall in-hospital mortality. Secondary outcomes included 28-day in-hospital mortality and the incidence of bacteraemia diagnosed based on blood culture findings. The discrimination, calibration and test performance of the qSOFA score were assessed. Missing data were handled using multiple imputation. RESULTS: Among the 507 haemodialysis patients admitted with bacteraemia suspicion between August 2011 and July 2013, the overall in-hospital mortality was 14.6% (74/507), the 28-day in-hospital mortality was 11.1% (56/507) and the incidence of bacteraemia, defined as a positive blood culture, was 13.4% (68/507). For predicting in-hospital mortality among haemodialysis patients, the area under the receiver operating characteristic curve was 0.61 (95% CI 0.56-0.67) for a qSOFA score ≥2. The Hosmer-Lemeshow χ statistics for the qSOFA score as a predictor of overall and 28-day in-hospital mortality were 5.72 (p=0.02) and 7.40 (p<0.01), respectively. CONCLUSION: On external validation, the qSOFA score exhibited low diagnostic accuracy and miscalibration for in-hospital mortality and bacteraemia among haemodialysis patients.
目的:本研究旨在检验快速序贯器官衰竭评估(qSOFA)评分对日本血液透析患者死亡和菌血症风险评估的有效性。
设计:这是一项回顾性多中心队列研究。
地点:参与研究的六家医院均为三级医疗机构,可接收急症患者并提供初级、二级和三级护理。另一家参与研究的医院为二级医疗机构,也可接收急症患者并提供初级和二级护理。
参与者:本研究纳入了因疑似菌血症而入院的血液透析门诊患者,这些患者在入院后 48 小时内接受了血液培养。
主要和次要结局指标:主要结局指标为全因院内死亡率。次要结局指标包括 28 天院内死亡率和基于血培养结果诊断的菌血症发生率。评估了 qSOFA 评分的区分度、校准度和检验效能。使用多重插补法处理缺失数据。
结果:在 2011 年 8 月至 2013 年 7 月期间,因疑似菌血症而入院的 507 例血液透析患者中,总的院内死亡率为 14.6%(74/507),28 天院内死亡率为 11.1%(56/507),血培养阳性定义的菌血症发生率为 13.4%(68/507)。对于预测血液透析患者的院内死亡率,qSOFA 评分≥2 分的受试者工作特征曲线下面积为 0.61(95%CI 0.56-0.67)。qSOFA 评分预测全因和 28 天院内死亡率的 Hosmer-Lemeshow χ 检验统计量分别为 5.72(p=0.02)和 7.40(p<0.01)。
结论:在外部验证中,qSOFA 评分对血液透析患者的院内死亡率和菌血症的诊断准确性较低,且校准度不佳。
Prehosp Emerg Care. 2017